Cargando…

Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure

Background The role of non-invasive (continuous positive airway pressure (CPAP) or Non-invasive ventilation (NIV)) respiratory support (NIRS) as a primary oxygenation strategy for COVID-19 patients with acute severe hypoxic respiratory failure (AHRF), as opposed to invasive mechanical ventilation (i...

Descripción completa

Detalles Bibliográficos
Autores principales: Booker, James, Egglestone, Rebecca, Lushington, Jack, Burova, Maria, Hamilton, Laura, Hunter, Elsie, Morden, Clare, Pandya, Darshni, Beecham, Ryan, MacKay, Robert, Gupta, Sanjay, Grocott, Michael P, Dushianthan, Ahilanandan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733975/
https://www.ncbi.nlm.nih.gov/pubmed/36514701
http://dx.doi.org/10.7759/cureus.32362
_version_ 1784846491856142336
author Booker, James
Egglestone, Rebecca
Lushington, Jack
Burova, Maria
Hamilton, Laura
Hunter, Elsie
Morden, Clare
Pandya, Darshni
Beecham, Ryan
MacKay, Robert
Gupta, Sanjay
Grocott, Michael P
Dushianthan, Ahilanandan
author_facet Booker, James
Egglestone, Rebecca
Lushington, Jack
Burova, Maria
Hamilton, Laura
Hunter, Elsie
Morden, Clare
Pandya, Darshni
Beecham, Ryan
MacKay, Robert
Gupta, Sanjay
Grocott, Michael P
Dushianthan, Ahilanandan
author_sort Booker, James
collection PubMed
description Background The role of non-invasive (continuous positive airway pressure (CPAP) or Non-invasive ventilation (NIV)) respiratory support (NIRS) as a primary oxygenation strategy for COVID-19 patients with acute severe hypoxic respiratory failure (AHRF), as opposed to invasive mechanical ventilation (invasive-MV), is uncertain. While NIRS may prevent complications related to invasive MV, prolonged NIRS and delays in intubation may lead to adverse outcomes. This study was conducted to assess the role of NIRS in COVID-19 hypoxemic respiratory failure and to explore the variables associated with NRIS failure. Methods This is a single-center, observational study of two distinct waves of severe COVID-19 patients admitted to the ICU. Patients initially managed with non-invasive respiratory support with laboratory-confirmed SARS-CoV-2 in acute hypoxaemic respiratory failure were included. Demographics, comorbidities, admission laboratory variables, and ICU admission scores were extracted from electronic health records. Univariate and multiple logistic regression was used to identify predictive factors for invasive mechanical ventilation. Kaplan-Meier survival curves were used to summarise survival between the ventilatory and time-to-intubation groups. Results There were 291 patients, of which 232 were managed with NIRS as an initial ventilation strategy. There was a high incidence of failure (48.7%). Admission APACHE II score, SOFA score, HACOR score, ROX index, and PaO2/FiO2 were all predictive of NIRS failure. Daily (days 1-4) HACOR scores and ROX index measurements highly predicted NIRS failure. Late NIRS failure (>24 hours) was independently associated with increased mortality (44%). Conclusion NIRS is effective as first-line therapy for COVID-19 patients with AHRF. However, failure, particularly delayed failure, is associated with significant mortality. Early prediction of NIRS failure may prevent adverse outcomes. 
format Online
Article
Text
id pubmed-9733975
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-97339752022-12-12 Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure Booker, James Egglestone, Rebecca Lushington, Jack Burova, Maria Hamilton, Laura Hunter, Elsie Morden, Clare Pandya, Darshni Beecham, Ryan MacKay, Robert Gupta, Sanjay Grocott, Michael P Dushianthan, Ahilanandan Cureus Anesthesiology Background The role of non-invasive (continuous positive airway pressure (CPAP) or Non-invasive ventilation (NIV)) respiratory support (NIRS) as a primary oxygenation strategy for COVID-19 patients with acute severe hypoxic respiratory failure (AHRF), as opposed to invasive mechanical ventilation (invasive-MV), is uncertain. While NIRS may prevent complications related to invasive MV, prolonged NIRS and delays in intubation may lead to adverse outcomes. This study was conducted to assess the role of NIRS in COVID-19 hypoxemic respiratory failure and to explore the variables associated with NRIS failure. Methods This is a single-center, observational study of two distinct waves of severe COVID-19 patients admitted to the ICU. Patients initially managed with non-invasive respiratory support with laboratory-confirmed SARS-CoV-2 in acute hypoxaemic respiratory failure were included. Demographics, comorbidities, admission laboratory variables, and ICU admission scores were extracted from electronic health records. Univariate and multiple logistic regression was used to identify predictive factors for invasive mechanical ventilation. Kaplan-Meier survival curves were used to summarise survival between the ventilatory and time-to-intubation groups. Results There were 291 patients, of which 232 were managed with NIRS as an initial ventilation strategy. There was a high incidence of failure (48.7%). Admission APACHE II score, SOFA score, HACOR score, ROX index, and PaO2/FiO2 were all predictive of NIRS failure. Daily (days 1-4) HACOR scores and ROX index measurements highly predicted NIRS failure. Late NIRS failure (>24 hours) was independently associated with increased mortality (44%). Conclusion NIRS is effective as first-line therapy for COVID-19 patients with AHRF. However, failure, particularly delayed failure, is associated with significant mortality. Early prediction of NIRS failure may prevent adverse outcomes.  Cureus 2022-12-09 /pmc/articles/PMC9733975/ /pubmed/36514701 http://dx.doi.org/10.7759/cureus.32362 Text en Copyright © 2022, Booker et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Anesthesiology
Booker, James
Egglestone, Rebecca
Lushington, Jack
Burova, Maria
Hamilton, Laura
Hunter, Elsie
Morden, Clare
Pandya, Darshni
Beecham, Ryan
MacKay, Robert
Gupta, Sanjay
Grocott, Michael P
Dushianthan, Ahilanandan
Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
title Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
title_full Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
title_fullStr Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
title_full_unstemmed Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
title_short Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
title_sort detailed analysis of primary non-invasive respiratory support and outcomes of subjects with covid-19 acute hypoxaemic respiratory failure
topic Anesthesiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733975/
https://www.ncbi.nlm.nih.gov/pubmed/36514701
http://dx.doi.org/10.7759/cureus.32362
work_keys_str_mv AT bookerjames detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT egglestonerebecca detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT lushingtonjack detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT burovamaria detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT hamiltonlaura detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT hunterelsie detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT mordenclare detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT pandyadarshni detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT beechamryan detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT mackayrobert detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT guptasanjay detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT grocottmichaelp detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure
AT dushianthanahilanandan detailedanalysisofprimarynoninvasiverespiratorysupportandoutcomesofsubjectswithcovid19acutehypoxaemicrespiratoryfailure